Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to evaluate the role of uterine natural killer cell(uNK)in recurrent pregnancy losses and the correlation between the numbers of it and embryo toxicity by measuring the level of the Th2 cytokines in normal reproductive profile and in patients with Recurrent Pregnancy Losses (RPL).


Clinical Trial Description

Office hysteroscopy examination of the patients at the luteal phase of the natural cycle (day17 to day 20),with endometrial biopsy using pipple curette from the region of the fundus, the biopsy sent to flow cytometry laboratory in South Egypt Cancer Institute to be examined for: 1.1. Phenotypic analysis of uterine natural killer cells: 1.2. Induction and detection of intracellular cytokines by flow Cytometry: ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01688284
Study type Interventional
Source Woman's Health University Hospital, Egypt
Contact
Status Terminated
Phase N/A
Start date March 2010
Completion date August 2012

See also
  Status Clinical Trial Phase
Completed NCT00456118 - Study of the Role of Tissular Maternofetal Alloimmunization in Placentation Pathologies
Recruiting NCT01661439 - Preconceptional Thromboprophylaxis in Recurrent PREGNANCY LOSSES Caused by Antiphospholipid Syndrome N/A